Related Experiment Video
Updated: May 29, 2026

Isolation and In vitro Culture of Bone Marrow-Derived Macrophages for the Study of NO-Redox Biology
Published on: May 31, 2022
Inhibition of nitric oxide synthesis in mouse macrophage cells by feverfew supercritical extract
Anat Aviram1, Nikolaos M Tsoukias, Steven J Melnick
1Miami Children's Hospital, Department of Pathology, Miami, FL 33155, USA.
Abstract:
Feverfew is the most commonly used medicinal herb against migraine headache. The antimigraine mechanism of feverfew supercritical extract was investigated in vitro using the mouse macrophage cell line (RAW 264.7). Mouse macrophage cells were treated with lipopolysaccharide in the presence and absence of feverfew extracts. Inhibition of lipopolysaccharide-induced nitric oxide and TNF-α synthesis were quantified by ELISA. The mRNA and protein expression of iNOS and eNOS genes were analysed by RT-PCR and western blot analysis, respectively. The feverfew extract inhibited both nitric oxide (NO) and TNF-α production in a dose-dependent manner with complete inhibition of NO occurring at 5 µg/mL of feverfew extract. Both eNOS and iNOS mRNA levels were unchanged with the feverfew treatment. However, eNOS and iNOS proteins were significantly down-regulated by the feverfew extract. Feverfew inhibition of NO is due to the down-regulation of both eNOS and iNOS enzymes at the translational and/or post-translational level.
Insights
Feverfew extract effectively reduces migraine-associated inflammation by inhibiting nitric oxide (NO) and TNF-α production. This mechanism involves down-regulating specific enzyme proteins, not their genetic material.
Area of Science:
- Pharmacology
- Immunology
- Herbal Medicine
Background:
- Feverfew (Tanacetum parthenium) is a widely recognized herbal remedy for migraine headaches.
- Understanding its anti-migraine mechanisms requires investigation at the cellular level.
Purpose of the Study:
- To elucidate the in vitro antimigraine mechanism of feverfew supercritical extract.
- To investigate the impact of feverfew on inflammatory mediators in a cellular model.
Main Methods:
- Utilized the mouse macrophage cell line (RAW 264.7) treated with lipopolysaccharide.
- Quantified nitric oxide (NO) and TNF-α synthesis using ELISA.
- Analyzed gene and protein expression of inducible nitric oxide synthase (iNOS) and endothelial nitric oxide synthase (eNOS) via RT-PCR and Western blot.
Main Results:
- Feverfew extract demonstrated dose-dependent inhibition of NO and TNF-α production.
- Complete inhibition of NO was observed at 5 µg/mL of feverfew extract.
- While mRNA levels of eNOS and iNOS remained unchanged, their protein expression was significantly down-regulated.
Conclusions:
- Feverfew's inhibition of NO synthesis is attributed to the down-regulation of eNOS and iNOS enzymes.
- This regulation occurs at the translational and/or post-translational levels, impacting protein expression rather than gene transcription.
Related Concept Videos
Methods of reducing fever
Pharmacological Methods of Reducing Fever:
Nitric Oxide Signaling Pathway
